01 / 12
Enquirer Consulting Group / Prepared for Intelliseq
September 2026

You asked what
we offer.

You asked a straight question, so here is the straight answer, specifically for Intelliseq rather than in general. What we can see from the outside, where we think the gap sits, and how we would run it. About three minutes end to end.
DesignBuildRunHand over
BUILDRUNOWN
Enquirer AI is the outbound engine of Enquirer Consulting Group
What we see

A growth engine that runs on other people's roadmaps. That is a hard thing to forecast.

01
iFlow does automated interpretation and reporting on sequencing data, standalone or plugged into the systems a lab already runs.
02
The named wins are all embeds: Oxford Gene Technology in 2023, the DNAnexus precision health data cloud in 2024, the Genomenon cancer knowledgebase in 2025.
03
The 2025 round was raised to push computational genetics and the US market. You are the US based commercial leader who arrived a few months later.
04
You own global growth from San Diego, and you describe the job as licensing, channel alliances and integrated platform deals.
Every one of those routes depends on a partner deciding how hard to sell iFlow this quarter. That is a real motion and it has clearly worked. It is also not a pipeline you control.
Prepared for Intelliseq
Where this goes

Partner led, plus a lane of your own.

Today
.
An embed puts iFlow in front of a partner's customers, on the partner's timetable, in the partner's words, against the partner's number.
.
Three integrations means three counterparties, each with their own roadmap. None of them wakes up owning your quarter.
.
A partnership motion is lumpy by design. It cannot be turned up on demand, and it does not produce a predictable count of first conversations.
.
The lab that already runs its own systems and has never heard of iFlow is not reachable through any of the three. Somebody has to go and find them.
In the first weeks and months
+
A named list of the US clinical labs, biopharma teams and digital health builders who would use an interpretation engine and have never had a conversation with Intelliseq, built by hand rather than bought.
+
A researched message per person, in your voice, about the interpretation and reporting bottleneck that team actually has rather than about the platform.
+
Direct outreach run as its own motion, on its own people, so it never competes with the partner deals you are already working.
+
Replies landing with a named owner and the context of who they are and what they said.
Enquirer Consulting Group
How the engagement works

Build. Run. Own.

01 / BUILD

Build

We design, staff and stand up the complete unit. The named-account data, the messaging, the outbound engine, the automation and the reporting.

02 / RUN

Run

We run it in market for a fixed four months and prove it on real booked meetings, not slides. First conversations land early.

03 / OWN

Own

We hand over the playbook, the tooling, the dashboards and a trained operator. You own the engine.

One contractor, a network of specialists. One point of contact, and you never manage a stack of tools or freelancers.
We build it, run it in market, then hand you the keys
What we build for Intelliseq

Three things, and only three.

The list, lab by lab

The US clinical labs, biopharma teams and digital health builders who would use an interpretation engine and have never had a conversation with Intelliseq. Named person by person, checked by hand. Not a bought file.

The outreach

A researched message per person across email and LinkedIn, written in your voice, aimed at the interpretation and reporting bottleneck that team actually has rather than at a feature list. One real person at a time.

The people who run it

We staff and operate the unit for a fixed four months. One point of contact, a dashboard you can audit, and no headcount for you to hire or manage while it proves out.

Three disciplines, not twelve. We would rather build the one thing that reaches the labs no integration puts you in front of than sell you the full menu.
Enquirer Consulting Group
The engine, in plain terms

Every message, written for one real person.

01

Target

The US clinical labs, biopharma teams and digital health builders who would use an interpretation engine and have never had a conversation with Intelliseq, named person by person.

02

Personalize

AI reads each profile and writes a unique message. No templates.

03

Hand off warm

A positive reply pings you and your operator with the prospect and a way to reach them.

04

You take it from there

You take pre-qualified conversations. The engine handles everything before it.

Research-led and human-reviewed. Every message is on-brand, and most of the volume runs on capacity we operate, not only your account.
Enquirer AI is the outbound engine of Enquirer Consulting Group
Why this fits Intelliseq

The partnerships keep compounding. This runs alongside them.

01

You own it at the end

A fixed four month build, then the playbook, the lists, the tooling and a trained operator are yours to keep and run. No agency sitting on a retainer forever.

02

It does not touch the partner motion

No partner account, no co-marketing, no channel conflict. Its whole job is to create direct conversations that no integration puts you in front of, then hand them over with the context attached.

03

Built to be argued with

You have sold into this market before, so you will know inside a week whether the list is right. Every name, every message and every reply is visible to you from day one, so you judge this on evidence rather than on a report.

Enquirer Consulting Group
Proof, in the field

Numbers from live campaigns, not projections.

Tim Rath
Chief Operating Officer, Innovative Radiology
Enquirer AI helps us identify the right people and start the conversation in a much smarter way.
$10M+
New business sold for clients.
3,500+
Qualified conversations generated.
100,000+
Decision makers reached for clients.
Fixed engagement, then you own it.
Why ECG

You own it at the end. That is the difference.

+
Without building an outbound team from scratch.
+
Without a permanent agency on retainer forever.
+
Without a stack of tools and freelancers to manage.
+
Without lock-in. You own the engine, including the operator who runs it.
A freelancer sends emails. An agency rents you reps. A consultancy hands you a slide deck. We design the engine, staff it, run it, prove it on real meetings, then hand you the keys.
Enquirer Consulting Group
How we start

Stand up fast. Prove it. Then scale.

Stand up

Build

The named-account data, the messaging, the engine and the dashboard. Day-one capacity from warmed assets and managed seats.

Prove

The test

Run against the KPIs we agree up front. First meetings on the calendar early.

Scale

Ramp

Once the numbers hold, ramp the seats and breadth to the volume you want.

Own

Hand over

Playbook, tooling, dashboards and a trained operator. The engine is yours.

Onboarding sets the targeting and the voice first, so the outreach lands warmer every week.
Enquirer Consulting Group
Next step

Let's see if the mechanism fits.

  1. A short call with Dan, 20 minutes, at a time that works for you.
  2. Dan brings a first named list of US labs and biopharma teams we would start with. You tell us where it is wrong.
  3. If it fits, we agree the scope and a start date. If it does not, you keep the list.
Reply to Dan with two or three times that suit and he will work around you.
Enquirer AI is the outbound engine of Enquirer Consulting Group
Enquirer Consulting Group

We build it, run it in market, then hand you the keys.

Dan Reeves   /   dan@enquirerconsulting.com   /   cal.com/ecg
Enquirer AI is the outbound engine of Enquirer Consulting Group. Prepared for Intelliseq.